search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Inside EICF


A Brand New Facility for Hot Isostatic Pressure Treatment Start Operations in Northern Spain


I The plant will


sostatic Toll Services Bilbao SL has recently opened a dedicated new facility in the area of Bilbao (Spain). be equipped with 2


identical AIP-52 units. Unit No. 1 is already fully operational, and the unit No. 2 will be installed by December 2020. Each unit consists of a water cooled monolithic forging of steel, integrated with molybdenum furnaces, vacuum pumps, compressors, and other high-tech accessory equipment, with full redundancy of the critical components. The redundancy is aiming to ensure Customers a Service Level of 95% availability of each year.


The hot zone of Ø1117 x 2539 mm will be the largest available in in southern Europe, capable to host large items such as engine blades, big


12 ❘ February 2020 ®


vanes, integral rings. Software and controlling system are provided by AIP operating on proprietary software to ensure full complicance with customer requirements


Isostatic Toll Services Bilbao SL will


benefit from the competence transferred by 3 relevant shareholders: ITS Inc, AIP Inc. and AMEPT LLC. ITS Inc, founded by the owner of AIP Inc, has 3 Toll HIPing facilities in US, representing the only case in the Western world of combined competence in design and operations of Hot Isostatic Presses.


The facility has been already


granted with the EN 9100 Approvals by Bureau Veritas and has successfully been audited and approved by Rolls & Royce and Pratt & Whitney. The


Safran approval is currently under way. Nadcap is planned for 2nd Semester 2020.


This new plant represents an


increase in the capacity available for HIP treatment in Europe, satisfying the Investment Casting increasing demand in market segments such as Aerospace and Bio medical implants.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104